1. Home
  2. CVV vs IGC Comparison

CVV vs IGC Comparison

Compare CVV & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

N/A

Current Price

$3.83

Market Cap

27.9M

Sector

Technology

ML Signal

N/A

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

N/A

Current Price

$0.19

Market Cap

32.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVV
IGC
Founded
1982
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
32.0M
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
CVV
IGC
Price
$3.83
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.0K
★ 573.5K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
17.86
★ 59.09
EPS
★ 1.58
N/A
Revenue
★ $41,128,639.00
$1,271,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.55
★ N/A
Revenue Growth
★ 96.27
N/A
52 Week Low
$2.96
$0.08
52 Week High
$9.10
$0.45

Technical Indicators

Market Signals
Indicator
CVV
IGC
Relative Strength Index (RSI) 35.78 18.22
Support Level $3.74 N/A
Resistance Level $4.44 $0.31
Average True Range (ATR) 0.20 0.02
MACD 0.09 -0.01
Stochastic Oscillator 36.90 54.35

Price Performance

Historical Comparison
CVV
IGC

About CVV CVD Equipment Corporation

CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: